BERKELEY'S NEWS • SEPTEMBER 27, 2022

tag

Patent Trial and Appeal Board

Page 1 of 1

The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office announced an interference between multiple UC and multiple Broad Institute patents, a signal that the USPTO will resolve the seven-year ownership debate regarding CRISPR-Cas9 genome editing in eukaryotic cells.
featured article
The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office announced an interference between multiple UC and multiple Broad Institute patents, a signal that the USPTO will resolve the seven-year ownership debate regarding CRISPR-Cas9 genome editing in eukaryotic cells.
featured article
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
featured article
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
featured article
The Patent Trial and Appeal Board heard arguments regarding a patent dispute over the methods employed in CRISPR, a natural bacterial defense mechanism that some scientists have used to modify DNA.
featured article
The Patent Trial and Appeal Board heard arguments regarding a patent dispute over the methods employed in CRISPR, a natural bacterial defense mechanism that some scientists have used to modify DNA.
featured article